Interestingly, while IFI16 primarily exerts its tumor-suppressive effects through nuclear DNA surveillance, elevated serum levels of this protein have paradoxically been associated with poor prognosis in BC patients (124). The gene discussed is IFI16; the disease is breast cancer.